Cost-effectiveness of modern inhalational anaesthetics using sevoflurane as an example;Okonomische Aspekte beim Einsatz moderner Inhalationsanesthatika am Beispiel des Sevofluran

Anaesthesist

Volumn 46, Issue 1, 1997, Pages 21-28

  Bach, A ^a,b   Bohrer H ^a   Schmidt, H ^a   Motsch, J ^a   Martin, E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Klinik fur Anaesthesiologie   (Germany)

Author keywords

anaesthetics; cost control; cost effectiveness; inhalation; sevoflurane

Indexed keywords

ALFENTANIL; ATRACURIUM BESILATE; DESFLURANE; ETOMIDATE; FENTANYL; INHALATION ANESTHETIC AGENT; ISOFLURANE; PANCURONIUM; PROPOFOL; SEVOFLURANE; SUFENTANIL; SUFENTANIL CITRATE; THIOPENTAL;

ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION;

ANESTHESIA DEPARTMENT, HOSPITAL; ANESTHESIA, INHALATION; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INHALATION; COST-BENEFIT ANALYSIS; ETHERS; HUMANS; METHYL ETHERS;

EID: 0031047510     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050366     Document Type: Article

References (31)

1. Bailey CR, Ruggier R, Cashman JN (1993) Anaesthesia: cheap at twice the price: Staff awareness, cost comparisons and recommendations for economic savings. Anaesthesia 48:906-909
2. Bauer H (1995) Zur Umsetzung des Gesundheitsstrukturgesetzes: Erfahrungen mit diagnosebezogenen Fallpauschalen in der Chirurgie. Zentralbl Chir 120:524-531
3. Becker KE, Carrithers J (1994) Practical methods of cost containment in anaesthesia and surgery. J Clin Anaesth 6:388-399
4. ®-Narkosegerät. Anaesthesist 42:638-643
5. Biro P, Suter G, Alon E (1995) Intravenöse Anästhesie mit Propofol versus Thiopental-/Enflurananästhesie. Anaesthesist 44:1633-170
6. Broadway PJ, Jones JG (1995) A method of costing anaesthetic practice. Anaesthesia 50:56-63
7. Cotter SM, Petros AJ, Doré CJ, Barber ND, White DC (1991) Low-flow anaesthesia. Anaesthesia 46:1009-1012
8. Fredman B, Nathanson MH, Smith I, Wang J, Klein K, White PF (1995) Sevoflurane for outpatient anesthesia: a comparison with propofol. Anesth Analg 81:823-828
9. Georgi R, Hoffmann R, Hempel V, Bräutigam KH (1987) Anästhesie-Kosten. Anästhesiol Intensivmed 28:288-295
10. Green G, Jonsson L (1993) Nausea: the most important factor determining length of stay after ambulatory anaesthesia. A comparative study of isoflurane and/or propofol techniques. Acta Anaesthesiol Scand 37:742-746
11. Hawkes C, Miller D, Martineau R, Hull K, Hopkins H, Tierney M (1994) Evaluation of cost minimization strategies of anaesthetic drugs in a tertiary care hospital. Can J Anaesth 41:894-901
12. Hemelrijck J, Smith I, White PF (1991) Use of desflurane for outpatient anesthesia. Anesthesiology 75:197-203
13. Horrow JC, Rosenberg H (1994) Price stickers do not alter drug usage. Can J Anaesth 41:1047-1052
14. Johnstone RE, Jozefczyk KG (1994) Costs of anesthetic drugs: Experiences with a cost education trial. Anesth Analg 78:766-771
15. Jones RM (1990) Desflurane and Sevoflurane: inhalation anaesthetics for this decade. Br J Anaesth 65:527-536
16. Kuhn I, Wissing H, Vettermann J (1995) Ein neues Arbeitsblatt zur Berechnung von Narkosekosten. Anästhesiol Intensivmed 36:242-248
17. Lill H, Sitter H, Klotter H-J, Nies C, Güntert-Görmann K, Rothmann M (1992) Was kostet die laparoskopische Cholecystektomie? Chirurg 63:1041-1044
18. Loscar M, Allhof T, Ott E, Conzen P, Peter K (1996) Aufwachverhalten und kognitive Funktion nach Desfluran oder Isofluran. Anaesthesist 45:140-145
19. Morscher AH, Smith CE, Gordon GJ, Patel N (1994) A simple spreadsheet tool for cost accounting anesthesia care. Anesthesiology 81:514-516
20. Orkin FK (1993) Moving toward value-based anesthesia care. J Clin Anesth 5:91-98
21. Pedersen FM, Nielsen J, Ibsen M, Guldager H (1993) Low-flow isoflurane-nitrous oxide anaesthesia offers substantial economic advantages over high- and medium-flow isoflurane-nitrous oxide anaesthesia. Acta Anaesthesiol Scand 37:509-512
22. Rhodes SP, Ridley S (1993) Economic aspects of general anaesthesia. Pharmacol Economics 3:124-130
23. Rolf N, Van Aken H (1995) Inhalationsanästhesie und intravenöse Anästhesie aus medizinischer und wirtschaftlicher Sicht. Anästhesiol Intensivmed Notfallmed Schmerzther 30:13-19
24. Sorgatz H, Biermann E, Fischer K (1995) Gesetzliche Änderungen für den stationären Bereich ab dem 01.01.1996. Anästh Intensivmed 36:348-352
25. Szocik JF, Learned DW (1994) Impact of a cost containment program on the use of volatile anesthetics and neuromuscular blocking drugs. J Clin Anesth 6:378-382
26. Szucs TD, Schramm W (1995) Wirtschaftlichkeitsuntersuchungen von medizinischen Therapien: Methodologische Grundlagen. Zentralbl Chir 120:577-583
27. Vitez TS (1994) Principles of cost analysis. J Clin Anesth 6:357-363
28. Weiskopf RB, Eger El (1993) Comparing the costs of inhaled anesthetics. Anesthesiology 79:1413-1418
29. White PF, Smith I (1993) Impact of newer drugs and techniques on the quality of ambulatory anesthesia. J Clin Anesth 5:3S-13S
30. White PF, Watcha MF (1993) Are new drugs cost-effective for patients undergoing ambulatory surgery. Anesthesiology 78:2-5
31. Wiesner G, Schwürzer S, Hörauf K, Hobbhahn J (1994) Aufwachzeiten, Kreislaufverhalten und unerwünschte Wirkungen bei Anwendung von Sevofluran und Isofluran. Anaesthesist 43:587-593